Immunome Inc. has granted inducement awards to a new employee, consisting of non-statutory stock options to purchase a total of 30,000 shares of common stock under its 2024 Inducement Plan. The options have an exercise price of $26.14 per share, based on the company's closing sales price on February 2, 2026. The vesting schedule stipulates that 25% of the shares will vest on the first anniversary of the vesting commencement date, with the remaining shares vesting monthly over the following 36 months, contingent on the employee’s continued service with the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260205435527) on February 05, 2026, and is solely responsible for the information contained therein.